Charles Davis, MD
Associate Professor of Medicine
MD: Medical College of Virginia, 1978
Phone: (410) 706-1684
Fax: (410) 706-3243
E-mail: davisc@umbi.umd.edu
Address:
Institute of Human Virology
725 West Lombard Street
Baltimore, MD 21201
RESEARCH INTERESTS
Dr. Davis' primary interest is in HIV, immunotherapy for the treatment of HIV, cell-cycle modification
to control HIV replication and as an adjunct to augment the activity of
nucleoside analogues in the treatment of HIV, and complementary therapy
for HIV treatment.
Dr. Davis is extensively
involved in clinical research, both, sponsored and unsponsored.
Current clinical trials include Phase I/II evaluation of potential vaccine
candidates for HIV immunotherapy; and Phase I clinical trials of a natural
product found in the skin of red grapes which augment the suppressive activity
of HIV-1 in vitro.
RECENT PUBLICATIONS
Heredia A, Davis C,
Redfield R: The synergistic inhibition of HIV-1 in activated and
peripheral blood mononuclear cells, monocyte-derived macrophages, and selected
drug-resistant isolates with nucleoside analogs combined with a natural
product, resveratrol. J Acquir Immune Defic Syndr 2000 Nov 1; 25(3):246-55.
Birx DL, Loomis-Price LD,
Aronson N, Brudgage J, Davis C, et al. Efficacy testing of
recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine
in early-stage HIV-1-infected volunteers. Rgp160 Phase II vaccine Investigators.
J Infect Dis. 2000; 181(3): 881-889.
Ratto-Kim S, Sitz KV, Garner
RP, Kim J, Davis C, et al: Repeated immunization with recombinant
gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1
infection: evaluation of the T cell proliferative response.
J Infect Dis. 1999; 179: 337-44.
Cox JH, Garner RP, Redfield
RR, Aronson NE, Davis C, Ruiz N, and Birx DL. Antibody-Dependent
Cellular Cytotoxicity in HIV Type 1-Infected Patients Receiving VaxSyn,
a Recombinant gp 160 Envelope Vaccine. AIDS Res Hum Retroviruses
1999; 15 (9): 847-854.
 Back to Primary Faculty
To contact us:
Phone: 410-706-7560
Fax: 410-706-4619
E-mail: kvardjan@ihv.umaryland.edu
 Back to Top of Page
| 
